Permissions vs Rights

At a glance

| Dimension | Rights (Entitlements) | Permissions (Privileges) | | :--- | :--- | :--- | | Simple Definition | Policy-level intent; what a user belongs to or can do. | Technical-level enforcement; specific actions allowed on a resource. | | Typical Use Case | Assigning an "Admin" or "Clinician" role to a new user. | Restricting "Read-Only" access to patient PHI within a database. | | Range / Scope | Broad and conceptual; encompasses multiple functional capabilities. | Granular and atomic; maps to CRUD operations or API calls. | | Security Posture | Defines the trust model and user responsibilities. | Implements Least Privilege by limiting specific execution capabilities. | | Common Attacks | Privilege escalation; horizontal movement via over-scoped roles. | Insecure Direct Object References (IDOR); bypass of functional constraints. | | FDA Relevance | Supports User Access Management documentation and cybersecurity risk assessment. | Evidence for technical controls (e.g., SW-68:2023) and audit log accuracy. | | Key Tradeoff | Easy to manage but prone to over-privileged "blanket" access. | High security precision but complex to configure and maintain. |

Quick definitions (plain language)

Rights are what an identity is allowed to do at a high level. Think of rights as the entitlement: “This user can administer devices” or “This account can perform remote service.”

Permissions are the specific, enforceable actions that implement a right. Think of permissions as the atomic controls: “can change therapy limits,” “can rotate keys,” “can export logs,” “can create users,” “can push configuration.”

In short:

• Rights = policy intent (who should be allowed to do what)
• Permissions = technical enforcement (the specific actions the system checks)

Why this matters in medical device ecosystems

Medical devices rarely exist alone. Your product may include:

• a device UI (local access)
• a cloud portal (remote access)
• APIs (integration access)
• a mobile app (end-user access)
• service tooling (field and support access)

If you can’t explain (and enforce) rights and permissions consistently across these surfaces, you’ll see common failures:

• Over-privileged roles (“everyone is an admin”)
• Authorization bypass (UI hides buttons, API still allows the action)
• Uncontrolled service access (shared accounts, long-lived credentials)
• Poor auditability (no clear record of who did what and when)

Rights vs permissions in real MedTech scenarios

Scenario 1: Clinician vs Biomed vs Patient

Right: “Clinician can configure therapy settings.”

Permissions: “can change dose limits,” “can update alarm thresholds,” “can confirm configuration change,” “can view configuration history.”

If you only define rights and not permissions, you risk bundling too much power into a single role and making least privilege impossible.

Scenario 2: Field service and remote support

Right: “Service technician can run diagnostics.”

Permissions: “can initiate self-test,” “can download logs,” “can view device identity,” “cannot change therapy parameters,” “cannot disable safety checks.”

This is where many programs fail: service workflows become the “superuser path” because they’re built for convenience instead of controlled access.

Scenario 3: Cloud portal administration

Right: “Org admin can manage users for their site.”

Permissions: “can invite user,” “can deactivate user,” “can assign role,” “cannot access another site’s devices,” “cannot view PHI outside scope.”

Multi-tenant boundaries and scoped admin privileges are where rights/permissions clarity pays off.

Common mistakes (and how to avoid them)

1) Treating UI controls as authorization

Hiding a button is not access control. Every privileged action must be enforced server-side (or in the device authorization layer) with explicit permission checks.

2) Bundling permissions into “God roles”

When roles are too coarse, teams grant the role to get one needed function and accidentally grant ten others. Start from least privilege and compose roles intentionally.

3) Using shared accounts

Shared logins destroy traceability. In regulated environments, you want identity-based accountability and clear audit trails.

4) Forgetting machine identities

Service accounts, device identities, API clients, and automated jobs also have rights and permissions. These identities are frequently the highest risk because they’re long-lived and rarely reviewed.

A practical model that works: RBAC + scoped permissions

Most MedTech teams do well with a simple approach:

See also: NFC & BLE Security in Medical Devices, ACLs for Medical Device Cybersecurity: Access Control Guide, and Windows LAPS for Medical Devices.

• Roles represent rights (Clinician, Biomed, Service Tech, Org Admin, Read-Only Auditor).
• Permissions are granular actions tied to objects (device, site, patient context, configuration set).
• Scope limits where the permission applies (this site, this device fleet, this tenant, this patient context).

For high-impact functions, consider adding:

• step-up authentication (re-authenticate for sensitive changes)
• two-person control for certain safety-critical actions
• time-bound access (just-in-time elevation for service workflows)

How this supports FDA-aligned evidence

FDA’s cybersecurity guidance emphasizes secure development practices and evidence that controls are designed, implemented, and verified across the lifecycle. Access control is a core part of that story.

See FDA’s current guidance here:

Cybersecurity in Medical Devices (Premarket + QMS Considerations).

Many teams map secure development practices to:

NIST SP 800-218 (SSDF),

including access control, secure defaults, and verification activities.

In practice, you want to be able to show:

• a role/permission matrix (rights mapped to permissions and scope)
• design rationale for least privilege (risk-based)
• verification evidence (tests proving enforcement on device + APIs)
• audit logging strategy (who did what, when, from where)
• postmarket monitoring triggers (abnormal privileged activity)

Verification checklist (what to test)

• Authorization checks on every privileged endpoint (not just UI)
• IDOR testing (can a user access another device/site by changing an identifier?)
• Role boundary tests (can read-only roles ever mutate state?)
• Service workflow constraints (are high-risk actions blocked for service roles?)
• Audit log completeness (actor, action, object, outcome, timestamp)
• Session and token handling for privileged actions

If you need independent validation, these are common starting points:

Medical Device Threat Modeling Services and

FDA-Compliant Vulnerability & Penetration Testing.

Key Takeaways

• Rights define policy intent; permissions enforce specific actions.
• MedTech products need consistent authorization across device, cloud, APIs, and service tooling.
• Least privilege is easiest when you define granular permissions and apply scope.
• Strong access control supports FDA-aligned evidence: design, verification, and postmarket monitoring.

Table of Contents

• At a glance
• Quick definitions (plain language)
• Why this matters in medical device ecosystems
• Rights vs permissions in real MedTech scenarios
• Common mistakes (and how to avoid them)
• A practical model that works: RBAC + scoped permissions
• How this supports FDA-aligned evidence
• Verification checklist (what to test)
• Key Takeaways
• Need help tightening access control in your product ecosystem?

How Blue Goat approaches this

Our approach to medical device access control focuses on clarity and enforcement, translating high-level rights into specific, auditable permissions. We work with your development and compliance teams to define and implement access control models that align with the principle of least privilege, directly addressing the complexities of diverse device UIs, cloud portals, and APIs.

Our experts, many of whom hold CISSP and OSCP certifications or have backgrounds in ex-military red teams, bring a practical, security-first mindset. We don't just identify vulnerabilities; we help you architect solutions that stand up to scrutiny. We also assist in developing the necessary documentation and evidence for regulatory submissions.

If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Learn more about how we can support your pre-market cybersecurity needs at Blue Goat Cyber's FDA Premarket Cybersecurity Services.

FAQ

What’s the simplest way to explain permissions vs rights?

Rights are the high-level entitlement (what a role is allowed to do). Permissions are the specific actions the system enforces to implement that entitlement.

Are permissions and authorization the same thing?

Permissions are inputs to authorization. Authorization is the decision the system makes: “Is this identity allowed to perform this action on this object in this context?”

Why is least privilege hard in connected medical devices?

Because access spans device UI, cloud portals, APIs, and service workflows. Without a consistent permission model and scope, teams over-grant access for convenience.

Do service accounts need permissions too?

Yes-often more than human users. Machine identities should be scoped, time-bound where possible, monitored, and reviewed regularly.

What evidence supports access control for FDA submissions?

A role/permission matrix, threat modeling outputs, test results demonstrating enforcement, and audit logging/monitoring procedures are common evidence elements.

Need help tightening access control in your product ecosystem?

If you want a practical, FDA-aligned approach to defining roles, enforcing permissions, and producing testable evidence, we can help.

Book a Discovery Session

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.